Gain Therapeutics, Inc.GANXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
20.53%
↑ 411% above average
Average (29q)
-6.60%
Historical baseline
Range
High:59.52%
Low:-91.08%
Volatility
-2282.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 20.53% |
| Q2 2025 | -18.75% |
| Q1 2025 | -14.29% |
| Q4 2024 | 17.65% |
| Q3 2024 | 59.52% |
| Q2 2024 | -90.91% |
| Q1 2024 | 24.14% |
| Q4 2023 | 21.62% |
| Q3 2023 | 40.32% |
| Q2 2023 | -44.19% |
| Q1 2023 | -10.26% |
| Q4 2022 | -2.63% |
| Q3 2022 | 11.63% |
| Q2 2022 | -53.57% |
| Q1 2022 | 12.50% |
| Q4 2021 | 17.95% |
| Q3 2021 | -30.00% |
| Q2 2021 | -42.86% |
| Q1 2021 | -40.00% |
| Q4 2020 | -91.08% |
| Q3 2020 | -46.18% |
| Q2 2020 | 6.93% |
| Q1 2020 | 17.69% |
| Q4 2019 | 36.27% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |